DNA Methylation: Its Role in Cancer Development and Therapy

This publication has 248 references indexed in Scilit:

• 2′-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: A novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1
  Cancer Letters, 2008
• DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
  British Journal of Cancer, 2008
• Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer
  Oncogene, 2007
• Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
  British Journal of Cancer, 2006
• DNA methylation and gene silencing in cancer
  Nature Clinical Practice Oncology, 2005
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
  New England Journal of Medicine, 2005
• DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
  Nature, 2002
• DNA methylation patterns and epigenetic memory
  Genes & Development, 2002
• Translating the Histone Code
  Science, 2001
• A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
  Oncogene, 1999